This track focuses on the underlying molecular processes that lead to the initiation and progression of cancer. Researchers will present findings on genetic mutations, epigenetic changes, and cellular signaling pathways involved in carcinogenesis.

This session will explore innovative therapeutic strategies for cancer treatment, including targeted therapies and immunotherapies. Participants will discuss the latest clinical trials and their implications for patient outcomes.

This track emphasizes the role of biomarkers in the early detection and diagnosis of various cancers. Presentations will cover novel diagnostic tools and their potential to improve clinical decision-making.

This session addresses current challenges in clinical oncology, including treatment resistance and patient management. Experts will share innovative approaches to enhance therapeutic efficacy and patient care.

This track will delve into the latest surgical techniques and their outcomes in the treatment of cancer. Discussions will include minimally invasive procedures and their impact on recovery and survival rates.

This session focuses on the pharmacological aspects of chemotherapeutic agents used in oncology. Researchers will present data on drug mechanisms, resistance, and the development of new pharmacological agents.

This track explores the intersection of immunology and oncology, highlighting the immune system's role in cancer progression and treatment. Presentations will cover novel immunotherapeutic approaches and their clinical applications.

This session will showcase cutting-edge research in experimental therapeutics aimed at improving cancer treatment outcomes. Participants will discuss preclinical studies and their translation to clinical practice.

This track focuses on the latest research and treatment strategies for hematological malignancies, including leukemia and lymphoma. Experts will discuss advancements in molecular oncology and therapeutic interventions.

This session will address the latest advancements in the diagnosis and treatment of gynecological cancers. Presentations will cover novel therapeutic approaches and their impact on patient outcomes.

This track examines the relationship between infectious diseases and cancer development from a molecular standpoint. Researchers will discuss the mechanisms by which certain pathogens may contribute to carcinogenesis.